Clinical Trial Update: Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on alternative non-cross-resistant adjuvant chemotherapy for operable breast cancer showing primary chemotherapy non-response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Operable Breast Cancer

Snippet

Sponsor: Tao OUYANG | Conditions: Primary Breast Cancer | Phase 3 | Status: UNKNOWN